Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
237.2 USD | +0.24% | +1.09% | -2.74% |
05-06 | Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating | MT |
05-03 | TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $260 From $271 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.74% | 68.54B | |
-3.54% | 185B | |
-0.58% | 109B | |
+4.84% | 51.74B | |
+10.40% | 45.22B | |
+3.12% | 41.74B | |
+2.87% | 26.69B | |
+4.61% | 26.83B | |
+11.62% | 25.63B | |
-0.22% | 24.98B |
- Stock Market
- Equities
- BDX Stock
- News Becton, Dickinson and Company
- Becton, Dickinson and Co. Enrolls First Person in Trial of Stent to Treat Peripheral Arterial Disease